US 8940773
Prolyl hydroxylase inhibitors and methods of use
granted A61KA61K31/4418A61K31/4433
Quick answer
US patent 8940773 (Prolyl hydroxylase inhibitors and methods of use) held by Akebia Therapeutics, Inc. expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Akebia Therapeutics, Inc.
- Grant date
- Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4418, A61K31/4433, A61P, A61P1/04